This work is the first report concerning CD38-CAR T cells redirected to multiple lymphoid malignancies (MM, WM, MCL, T-ALL, and NKTCL) cells and/or xenograft tumors. This evidence concerns the gene CD38 and extranodal nasal NK/T cell lymphoma.